HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

asperchalasine A

from Aspergillus flavipes; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Cytochalasins: 40
        asperchalasine A: 1
Biological Factors: 2472
- Biological Toxins: 20
  - Mycotoxins: 1745
    - Cytochalasins: 40
      - asperchalasine A: 1

Experts

1.	Ji, Young Seok: 1 article (12/2019)
2.	Kang, Ki Sung: 1 article (12/2019)
3.	Kim, Young-Joo: 1 article (12/2019)
4.	Park, Do Hwi: 1 article (12/2019)
5.	Park, Jun Yeon: 1 article (12/2019)
6.	Yoo, Hye Hyun: 1 article (12/2019)
7.	Zhang, Yonghui: 1 article (12/2019)
8.	Zhu, Hucheng: 1 article (12/2019)

Related Diseases

1.	Neoplasms (Cancer) 12/01/2019 - "This study also suggests that Aspergillus extract and its active component asperchalasine A are excellent candidates as adjuvant therapeutic substances for cancer prevention and treatment."